Institute of Predictive and Personalized Medicine of Cancer IMPPC, Ctra. de Can Ruti, Camí de les Escoles s/n, 08916, Badalona, Barcelona, Spain.
Orphanet J Rare Dis. 2013 Feb 19;8:30. doi: 10.1186/1750-1172-8-30.
Hereditary Hyperferritinaemia Cataract Syndrome (HHCS) is a rare autosomal dominant disease characterized by increased serum ferritin levels and early onset of bilateral cataract. The disease is caused by mutations in the Iron-Responsive Element (IRE) located in the 5' untranslated region of L-Ferritin (FTL) mRNA, which post-transcriptionally regulates ferritin expression.
We describe two families presenting high serum ferritin levels and juvenile cataract with novel mutations in the L-ferritin IRE. The mutations were further characterized by in vitro functional studies.
We have identified two novel mutations in the IRE of L-Ferritin causing HHCS: the Badalona +36C > U and the Heidelberg +52 G > C mutation. Both mutations conferred reduced binding affinity on recombinant Iron Regulatory Proteins (IPRs) in EMSA experiments. Interestingly, the Badalona +36C > U mutation was found not only in heterozygosity, as expected for an autosomal dominant disease, but also in the homozygous state in some affected subjects. Additionally we report an update of all mutations identified so far to cause HHCS.
The Badalona +36C > U and Heidelberg +52 G > C mutations within the L-ferritin IRE only mildly alter the binding capacity of the Iron Regulatory Proteins but are still causative for the disease.
遗传性铁蛋白血症白内障综合征(HHCS)是一种罕见的常染色体显性遗传病,其特征为血清铁蛋白水平升高和双侧白内障早发。该疾病由位于 L-铁蛋白(FTL)mRNA 5'非翻译区的铁反应元件(IRE)中的突变引起,该突变在后转录水平上调节铁蛋白的表达。
我们描述了两个家族,它们表现出高血清铁蛋白水平和青少年白内障,具有 L-铁蛋白 IRE 中的新突变。进一步通过体外功能研究对突变进行了表征。
我们在 L-铁蛋白的 IRE 中发现了两个导致 HHCS 的新突变:Badalona +36C > U 和 Heidelberg +52 G > C 突变。这两种突变在 EMSA 实验中均导致重组铁调节蛋白(IRPs)的结合亲和力降低。有趣的是,Badalona +36C > U 突变不仅在杂合子中发现,如常染色体显性疾病所预期的那样,而且在一些受影响的受试者中也发现了纯合子状态。此外,我们报告了迄今为止导致 HHCS 的所有突变的最新情况。
L-铁蛋白 IRE 内的 Badalona +36C > U 和 Heidelberg +52 G > C 突变仅轻微改变铁调节蛋白的结合能力,但仍然是该疾病的致病原因。